Literature DB >> 7326903

Bioluminescent assay of adenine nucleotides: rapid analysis of ATP and ADP in red cells and platelets using the LKB luminometer.

G P Summerfield, J P Keenan, N J Brodie, A J Bellingham.   

Abstract

The assessment of both red cell and platelet function requires assay of adenine nucleotides. We describe the use of the new LKB luminometer to measure adenosine triphosphate (ATP) and adenosine diphosphate (ADP) by bioluminescence in both normal and abnormal red cells and platelets. ATP was measured a in a lysate of red cells suspended in buffer, pH 7.4, b in ethanol extracts of platelets from platelet-rich plasma (PRP) and c in ethanol extracts of supernatant platelet-poor plasma (PPP) following platelet aggregation by collagen. ADP was measured as ATP after phosphorylation by pyruvate kinase (PK) with phosphoenolpyruvate (PEP). Duplicate assays showed a variance of less than 3%. Red cell lysates and ethanol extracts of PRP and PPP stored at -40 degrees C were stable for 4 weeks. Duplicate assays of ATP and ADP in eight samples plus standards could be performed in 2 h. Normal values were: red cells (microM/ml red cells) (n = 20), ATP 1.15 +/- 0.17 (1 SD), ADP 0.22 +/- 0.07, ATP/ADP (mean ratio) 5.76:1, platelets (nm/10(9) platelets) (n = 20), ATP 53.3 +/- 7.6, ADP 27.8 +/- 5.8, ATP/ADP (mean ratio: 1.96:1). Abnormalities of red cell ATP and/or ADP could be demonstrated in chronic renal failure, hereditary glycolytic enzyme deficiencies and other haemolytic states. In myeloproliferative disorders defective platelet aggregation associated with storage pool deficiency and/or impaired release of ADP and ATP could be shown. We conclude that this is a reliable, rapid and economical technique for measuring red cell and platelet adenine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326903     DOI: 10.1111/j.1365-2257.1981.tb01340.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  7 in total

1.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

Review 2.  Laboratory investigation of platelet function: a review of methodology.

Authors:  D A Yardumian; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

3.  Bioenergetic consequences of catabolic shifts by Lactobacillus plantarum in response to shifts in environmental oxygen and pH in chemostat cultures.

Authors:  C P Tseng; J L Tsau; T J Montville
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

4.  Diagnosis and Management of Inherited Platelet Disorders.

Authors:  Carl Maximilian Kirchmaier; Daniele Pillitteri
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

5.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.

Authors:  F R Ahmann; H S Garewal; R Schifman; A Celniker; S Rodney
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

6.  Adenine nucleotide concentrations in patients with erythrocyte autoantibodies.

Authors:  V F Strong; R J Sokol; S A Rodgers; S Hewitt
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

7.  Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency.

Authors:  Ivar van Asten; Maaike Blaauwgeers; Lianne Granneman; Harry F G Heijnen; Marieke J H A Kruip; Erik A M Beckers; Michiel Coppens; Jeroen Eikenboom; Rienk Y J Tamminga; Gerard Pasterkamp; Albert Huisman; Karin P M van Galen; Suzanne J A Korporaal; Roger E G Schutgens; Rolf T Urbanus
Journal:  J Thromb Haemost       Date:  2019-12-27       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.